中国实用医刊
中國實用醫刊
중국실용의간
CENTRAL PLAINS MEDICAL JOURNAL
2014年
18期
5-8
,共4页
王静波%高峰%张晓锦%卫宏江%党浩丹%陈杰%赵杰%贺俊保
王靜波%高峰%張曉錦%衛宏江%黨浩丹%陳傑%趙傑%賀俊保
왕정파%고봉%장효금%위굉강%당호단%진걸%조걸%하준보
肝脏铁沉积%磁共振成像%血清铁蛋白
肝髒鐵沉積%磁共振成像%血清鐵蛋白
간장철침적%자공진성상%혈청철단백
Liver iron deposition%Magnetic resonance imaging%Serum ferritin
目的:探讨磁共振( MRI)成像技术对血液病长期输血患者全肝脏铁沉积状况的评估价值。方法选取因血液病长期输血的患者100例及正常人30例为研究对象,将患者按输血量进行分组,行MRI全肝铁功能成像检查,根据MRI T2值纳入肝脏铁过载的患者,检测其血清铁蛋白( SF),分析SF与MRI T2值的相关性。对符合去铁治疗标准的患者予以去铁胺干预,治疗1、3个月后检测SF和MRI T2值,观察铁沉积的转归。结果经MRI检测,100例患者中有82例为肝脏铁过载,其血清铁蛋白值明显高于正常人,且与肝脏 MRI T2值呈负相关( r =-0.709,P=0.00)。其中76例患者接受去铁治疗,与治疗前相比,治疗后1、3个月SF水平明显降低(P﹤0.05),肝脏MRI T2值明显升高(P﹤0.05)。治疗后3个月的总反应率与1个月时比较,差异有统计学意义(P﹤0.05)。结论 MRI成像在评估血液病长期输血患者全肝脏铁沉积状况方面有重要的临床价值。
目的:探討磁共振( MRI)成像技術對血液病長期輸血患者全肝髒鐵沉積狀況的評估價值。方法選取因血液病長期輸血的患者100例及正常人30例為研究對象,將患者按輸血量進行分組,行MRI全肝鐵功能成像檢查,根據MRI T2值納入肝髒鐵過載的患者,檢測其血清鐵蛋白( SF),分析SF與MRI T2值的相關性。對符閤去鐵治療標準的患者予以去鐵胺榦預,治療1、3箇月後檢測SF和MRI T2值,觀察鐵沉積的轉歸。結果經MRI檢測,100例患者中有82例為肝髒鐵過載,其血清鐵蛋白值明顯高于正常人,且與肝髒 MRI T2值呈負相關( r =-0.709,P=0.00)。其中76例患者接受去鐵治療,與治療前相比,治療後1、3箇月SF水平明顯降低(P﹤0.05),肝髒MRI T2值明顯升高(P﹤0.05)。治療後3箇月的總反應率與1箇月時比較,差異有統計學意義(P﹤0.05)。結論 MRI成像在評估血液病長期輸血患者全肝髒鐵沉積狀況方麵有重要的臨床價值。
목적:탐토자공진( MRI)성상기술대혈액병장기수혈환자전간장철침적상황적평고개치。방법선취인혈액병장기수혈적환자100례급정상인30례위연구대상,장환자안수혈량진행분조,행MRI전간철공능성상검사,근거MRI T2치납입간장철과재적환자,검측기혈청철단백( SF),분석SF여MRI T2치적상관성。대부합거철치료표준적환자여이거철알간예,치료1、3개월후검측SF화MRI T2치,관찰철침적적전귀。결과경MRI검측,100례환자중유82례위간장철과재,기혈청철단백치명현고우정상인,차여간장 MRI T2치정부상관( r =-0.709,P=0.00)。기중76례환자접수거철치료,여치료전상비,치료후1、3개월SF수평명현강저(P﹤0.05),간장MRI T2치명현승고(P﹤0.05)。치료후3개월적총반응솔여1개월시비교,차이유통계학의의(P﹤0.05)。결론 MRI성상재평고혈액병장기수혈환자전간장철침적상황방면유중요적림상개치。
Objective To study the evaluation value of MRI T2 technique on liver iron deposi-tion status in patients with long-term blood transfusion for blood disease. Methods One hundred pa-tients with long-term blood transfusion for blood disease and 30 healthy persons were included in this study. The liver iron deposition status of 100 patients were divided into 5 groups according to their volume of blood transfusion. Serum ferritin levels of the patients with liver iron overload were measured and the correlation between the levels of SF and values of liver MRI T2 was analyzed. The patients who met the standard of iron chelation therapy received the treatment of deferoxamine. The levels of SF and values of liver MRI T2 were tested after 1 month and 3 months of treatment and the development of iron deposition was observed. Results The levels of SF of 82 patients with liver iron overload were significantly higher than those of healthy persons and were negatively related to the values of liver MRI T2( r= -0. 709 ,P=0. 00 ). Seventy-six patients received the treatment of deferoxamine and their levels of SF were significant-ly decreased( P﹤0. 05 ),and the values of liver MRI T2 were significantly increased( P﹤0. 05 )after 1 month and 3 months compared with the results before treatment. There was significant differences in the total reaction rate between 3 months and 1 month after treatment( P﹤0. 05 ). Conclusions The clinical evaluation value of MRI T2 technique on liver iron deposition status in patients with long-term blood transfusion for blood disease is high.